Granules India plans ₹2,000 crore investment to drive growth in complex generics, oncology, and peptide CDMO
Comment / Reply From
You May Also Like
Popular Posts
Newsletter
Subscribe to our mailing list to get the new updates!
Subscribe to our mailing list to get the new updates!
Subscribe to our newsletter